Bioflavonoid stimulation of glutathione transport by the 190-kDa multidrug resistance protein 1 (MRP1)

Drug Metabolism and Disposition

Volumn 31, Issue 1, 2003, Pages 11-15

  Leslie, Elaine M ^a   Deeley, Roger G ^a   Cole, Susan P C ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC AGENT; APIGENIN; BIOFLAVONOID; GENISTEIN; GLUTATHIONE; MULTIDRUG RESISTANCE PROTEIN 1; NARINGENIN; ORGANIC ANION TRANSPORTER; QUERCETIN; TRIPEPTIDE;

ARTICLE; CANCER RESISTANCE; CELL MEMBRANE TRANSPORT; CHEMOSENSITIVITY; CONTROLLED STUDY; ENZYME ACTIVATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IC 50; MEMBRANE VESICLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; TUMOR CELL;

APIGENIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVANONES; FLAVONOIDS; GENISTEIN; GLUTATHIONE; HELA CELLS; HUMANS; MOLECULAR WEIGHT; P-GLYCOPROTEIN; PROTEIN TRANSPORT;

EID: 0013016426     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: 10.1124/dmd.31.1.11     Document Type: Article

References (28)

1. Cantin AM, North SL, Hubbard RC, and Crystal RG (1987) Normal alveolar epithelia lining fluid contains high levels of glutathione. J Appl Physiol 63:152-157.
2. Cole SPC, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC Stewart AJ, Kurz EU, Duncan AMV, and Deeley RG (1992) Overexpression of a transporter Gene in a multidrug-resistant human lung cancer cell line. Science (Wash DC) 258:1650-1654.
3. Cole SPC, Sparks KE, Fraser K, Loe DW, Grant CE, Wilson GM, and Deeley RG (1994) Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res 54:5902-5910.
4. Galati G, Chan T, Wu B. and O'Brien PJ (1999) Glutathione-dependent generation of reactive oxygen species by the peroxidase-catalyzed redox cycling of flavonoids. Chem Res Toxicol 12:521-525.
5. Hooijberg JH, Broxterman HJ, Heijn M, Fles DLA, Lankelma J, and Pinedo HM (1997) Modulation by (iso)flavonoids of the ATPase activity of the multidrug resistance protein. FEBS Lett 413:344-348.
6. Hooijberg JH, Broxterman HJ, Scheffer GL, Vrasdonk C, Heijn M. de Jong MC, Scheper RJ, Lankelma J, and Pinedo HM (1999) Potent interaction of flavopiridol with MRP1. Br J Cancer 81:269-276.
7. Hooijberg JH, Pinedo HM, Vrasdonk C, Priebe W, Lankelma J, and Broxterman HJ (2000) The effect of glutathione on the ATPase activity of MRP1 in its natural membranes. FEBS Lett 469:47-51.
8. Jedlitschky G, Leier I, Buchholz U, Center M, and Keppler D (1994) ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein. Cancer Res 54:4833-4836.
9. Leslie EM. Deeley RG, and Cole SPC (2001c) Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters. Toxicology 167:3-23.
10. Leslie EM, Ito K, Upadhyaya P, Hecht SS, Deeley RG, and Cole SPC (2001b) Transport of the β-O-glucuronide conjugate of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by the multidrug resistance protein 1 (MRP1): requirement for glutathione or a non-sulfur-containing analog. J Biol Chem 276:27846-27854.
11. Leslie EM, Mao Q, Oleschuk CJ, Deeley RG, and Cole SPC (2001a) Modulation of multidrug resistance protein 1 (MRP1/ABCC1) transport and ATPase activities by interaction with dietary flavonoids. Mol Phamacol 59:1171-1180.
12. Loe DW, Almquist KC, Deeley RG, and Cole SPC (1996) Multidrug resistance protein (MRP)-mediated transport of leukotriene C4 and chemotherapeutic agents in membrane vesicles: Demonstration of glutathione-dependent vincristine transport. J Biol Chem 271:9675-9682.
13. Loe DW, Deeley RG, and Cole SPC (1998) Characterization of vincristine transport by the 190 kDa multidrug resistance protein, MRP: evidence for co-transport with reduced glutathione, Cancer Res 58:5130-5136.
14. Loe DW, Deeley RG, and Cole SPC (2000a) Verapamil stimulates glutathione transport by the multidrug resistance protein 1 (MRP1). J Pharmacol Exp Ther 293:530-538.
15. 4 and reduced glutathione by multidrug resistance protein MRP1. Biochem Biophys Res Commun 275:795-803.
16. Myhrstad MC, Carlsen H, Nordstrom O, Blomhoff R, and Moskaug JJO (2002) Flavonoids increase the intracellular glutathione level by transactivation of the gamma-glutamylcysteine synthetase catalytical subunit promoter. Free Radic Biol Med 32:386-393.
17. Ookhtens M and Kaplowitz N (1998) Role of the liver in interorgan homeostasis of glutathione and cyst(e)ine. Semin Liver Dis 18:313-329.
18. Paulusma CC, van Geer MA, Evers R, Heijn M, Ottenhoff R, Borst P, and Oude Elferink RPJ (1999) Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione. Biochem J 338:393-401.
19. Qian YM, Song WC, Cui H-R, Cole SPC, and Deeley RG (2001) Glutathione stimulate sulfated estrogen transport by multidrug resistance protein 1. J Biol Chem 276:6404-6411.
20. Rappa G. Lorico A, Flavell RA, and Sartorelli AC (1997) Evidence that the multidrug resistance protein (MRP) functions as a co-transporter of glutathione and natural product toxins. Cancer Res 57:5232-5237.
21. Ratty AK and Das NP (1988) Effects of flavonoids on nonenzymatic lipid peroxidation: structure-activity relationship. Biochem Med Metab Biol 39:69-79.
22. Robbiani DF, Finch RA, Jager D, Muller WA, Sartorelli AC, and Randolph GW (2000) The leukotriene C4 transporter MRP1 regulates CCL19 (M1P-3B, ELC)-dependent mobilization of dendritic cells to lymph nodes. Cell 103:757-768.
23. Ross JA and Kasum CM (2002) Dietary flavonoids: bioavailability, metabolic effects and safety. Annu Rev Nutr 22:19-34.
24. Sakamoto H, Hara H, Hirano K, and Adachi T (1999) Enhancement of glucuronosyl etoposide transport by glutathione in multidrug resistance-associated protein-overexpressing cells. Cancer Lett 135:113-119.
25. Versantvoort CHM, Broxterman HJ, Bagrij T, Scheper RJ, and Twentyman PR (1995) Regulation by glutathione of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistance-associated protein. Br J Cancer 72:82-89.
26. Versantvoort CHM, Schuurhuis GJ, Pinedo HM, Eekman CA, Kuiper CM, Lankelma J, and Broxterman H (1993) Genistein modulates the decreased drug accumulation in non-P-glycoprotein mediated multidrug resistant tumour cells. Br J Cancer 68:939-946.
27. Wijnholds J, Evers R, Van Leusden MR, Mol CAAM, Zaman GJR, Mayer U, Beijnen JH, van der Valk M, Krimpenfort P, and Borst P (1997) Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein. Nat Med 3:1275-1279.
28. Zaman GJR, Lankelma J, van Tellingen O, Beijnen J, Dekker H, Paulusma C, Oude Elferink RPJ, Baas F, and Borst P (1995) Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. Proc Natl Acad Sci USA 92:7690-7694.